Luoxin Pharmaceuticals Group Competitors and Similar CompaniesClear all

Luoxin Pharmaceuticals Group's competitors and similar companies include McKesson Europe, Alkem Laboratories, Macleods Pharmaceuticals and Sanofi Pasteur.

	Luoxin Pharmaceuticals Group Luoxin Pharmaceuticals Group (罗欣药业集团) is a company that produces and trades drugs.	McKesson Europe McKesson Europe is a trading company that provides logistics and services in the pharmaceutical and healthcare sector.	Alkem Laboratories Alkem Laboratories is a pharmaceutical company that operates globally.	Macleods Pharmaceuticals Macleods Pharmaceuticals is a company involved in pharmaceutical research, development, and manufacturing.	Sanofi Pasteur Sanofi Pasteur is a pharmaceutical company that develops, manufactures, and supplies vaccines.
Founding Date	Founding Date 2006	Founding Date 1835	Founding Date 1973	Founding Date 1986	Founding Date 1989
Type	Type Public	Type Subsidiary	Type Public	Type Private	Type Subsidiary
Tags	Tags Healthcare drug development pharma	Tags Healthcare drug development pharma	Tags Healthcare drug development pharma	Tags Healthcare drug development pharma	Tags Healthcare drug development pharma
Locations	Locations Linyi, CN HQ	Locations Stuttgart, DE HQ	Locations HQ Mumbai, IN Almaty, KZ Makati, PH	Locations Mumbai, IN HQ Almaty, KZ Kuala Lumpur, MY Taguig, PH Alberton, ZA Kyiv, UA see more	Locations Lyon, FR HQ
Employees	Employees 3,388	Employees 26,329	Employees 14,331	Employees 11,1491% increase	Employees 6,7454% increase
Financial
Revenue (est.)	Revenue (est.) ¥2.2b (FY, 2025)	Revenue (est.) €18b (FY, 2022)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) €2.8b (FY, 2021)
Cost of goods	Cost of goods ¥1.1b (FY, 2025)	Cost of goods €16.1b (FY, 2022)	Cost of goods N/A	Cost of goods N/A	Cost of goods €505m (FY, 2021)
Gross profit	Gross profit ¥1.1b (FY, 2025)	Gross profit €1.9b (FY, 2022)	Gross profit N/A	Gross profit N/A	Gross profit €2.3b (FY, 2021)
Net income	Net income (¥284.5m) (FY, 2025)	Net income (€867.4m) (FY, 2022)	Net income N/A	Net income N/A	Net income €605m (FY, 2021)